SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 432.59 |
Enterprise Value ($M) | 195.56 |
Book Value ($M) | 240.98 |
Book Value / Share | 8.90 |
Price / Book | 1.80 |
NCAV ($M) | 202.89 |
NCAV / Share | 7.49 |
Price / NCAV | 2.13 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.30 |
Return on Assets (ROA) | -0.19 |
Return on Equity (ROE) | -0.29 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.67 |
Current Ratio | 4.67 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 305.98 |
Assets | 344.07 |
Liabilities | 103.09 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 152.31 |
Operating Income | -95.67 |
Net Income | -80.94 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -59.75 |
Cash from Investing | -0.65 |
Cash from Financing | 5.42 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | State Street Corp | 4.90 | -18.62 | |
13G | Nikko Asset Management Americas, Inc. | 8.56 | 75.31 | |
13G | Sumitomo Mitsui Trust Holdings, Inc. | 8.56 | 75.31 | |
13G/A | BlackRock, Inc. | 10.20 | 14.37 | |
13G/A | Vanguard Group Inc | 5.46 | 0.55 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
197,808 | 699,940 | 28.26 | |
51,323 | 259,071 | 19.81 | |
77,500 | 264,002 | 29.36 | |
78,443 | 390,604 | 20.08 | |
63,391 | 294,224 | 21.55 | |
(click for more detail) |
Similar Companies | |
---|---|
APGE – Apogee Therapeutics, Inc. | APLT – Applied Therapeutics, Inc. |
AQST – Aquestive Therapeutics, Inc. | ARDX – Ardelyx, Inc. |
ATAI – Atai Life Sciences N.V. |
Financial data and stock pages provided by
Fintel.io